Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

Mitochondrial Fission, Fusion, and Stress

Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · see citing works

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Bredt, D. S., & Snyder, S. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.682 · Cited by 3,308 · see citing works

LXXIII.—Oxidation of tartaric acid in presence of iron

Fenton, H. J. H. (1894) · J. Chem. Soc., Trans. · doi:10.1039/ct8946500899 · Cited by 3,179 · see citing works

α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 3,151 · see citing works

Localization of nitric oxide synthase indicating a neural role for nitric oxide

Bredt, D. S., Hwang, P. M., & Snyder, S. H. (1990) · Nature · doi:10.1038/347768a0 · Cited by 2,981 · see citing works

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737 · see citing works

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

The reaction of NO with superoxide

Huie, R. E., & Padmaja, S. (1993) · Free Radical Research Communications · doi:10.3109/10715769309145868 · Cited by 2,121 · see citing works

α-synuclein locus duplication as a cause of familial Parkinson's disease

Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029 · see citing works

Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · see citing works

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845 · see citing works

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722 · see citing works

Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System

Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722 · see citing works

The many faces of α-synuclein: from structure and toxicity to therapeutic target

Lashuel, H. A., Overk, C., Oueslati, A., & Masliah, E. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3406 · Cited by 1,623 · see citing works

Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes

Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,588 · see citing works

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569 · see citing works

Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions

Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,551 · see citing works

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,543 · see citing works

Oxidation of tartaric acid in presence of iron

Fenton, H. J. H. (1894) · Journal of the Chemical Society (Resumed) · Cited by 1,498 · see citing works

In vivo demonstration that α-synuclein oligomers are toxic

Winner, B., Jappelli, R., Maji, S. K., Desplats, P., Boyer, L. F., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,487 · see citing works

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · see citing works

Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations

Arnold, W. P., Mittal, C. K., Katsuki, S., & Murad, F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.8.3203 · Cited by 1,459 · see citing works

The Haber–Weiss reaction and mechanisms of toxicity

Kehrer, J. P. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00231-6 · Cited by 1,418 · see citing works

Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354 · see citing works

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · see citing works

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 1× · see citing works

Amyloid pores from pathogenic mutations

Lashuel, H. A., Hartley, D. M., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,291 · see citing works

Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct

Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127 · see citing works

Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones

GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126 · see citing works

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.10043 · Cited by 1,097 · see citing works

Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation

Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096 · see citing works

Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity

Nucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J. C., Dawson, V. L., et al. (2001) · Science · doi:10.1126/science.1056784 · Cited by 1,095 · see citing works

Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain

Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,087 · see citing works

Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. ‐. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,087 · see citing works

Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. Wright

Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,077 · see citing works

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

Steffan, J. S., Kazantsev, A. G., Spasić-Bošković, O., Greenwald, M., Zhu, Y., Goehler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,057 · see citing works

Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

Nemani, V. M., Lü, W., Berge‐Seidl, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,051 · see citing works

Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease

Ibáñez, P., Bonnet, A. M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,042 · see citing works

Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012 · see citing works

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

Nalls, M., Plagnol, V., Hernandez, D., Sharma, M., Sheerin, U., Saad, M., Simón-Sánchez, J., Schulte, C., Lesage, S., Sveinbjörnsdóttir, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 986 · see citing works

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.

Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981 · see citing works

Structure and Dynamics of Micelle-bound Human α-Synuclein

Ulmer, T. S., Bax, A., Cole, N. B., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411805200 · Cited by 966 · see citing works

Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

Luk, K. C., Song, C., O’Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 958 · see citing works

The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927 · see citing works

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844 · see citing works

Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology

Outeiro, T. F., & Lindquist, S. L. (2003) · Science · doi:10.1126/science.1090439 · Cited by 808 · see citing works

α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular Protofibrils

Lashuel, H. A., Petre, B. M., Wall, J. S., Simon, M. N., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 802 · see citing works

Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

Lee, H.-J., Patel, S. S., & Lee, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 798 · see citing works

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · see citing works

Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons

Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 753 · see citing works

α-Synuclein Fibrillogenesis Is Nucleation-dependent

Wood, S. J., Wypych, J., Steavenson, S., Louis, J., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 719 · see citing works

α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress

Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E. M., Sisk, A., Mallory, M. E., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 716 · see citing works

Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease

El‐Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., & Allsop, D. (2006) · The FASEB Journal · doi:10.1096/fj.03-1449com · Cited by 715 · see citing works

Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation

Narhi, L. O., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F. H., Sitney, K. C., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710 · see citing works

Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697 · see citing works

Pathoanatomy of Parkinson’s disease

Braak, H., & Braak, E. (2000) · Journal of Neurology · doi:10.1007/pl00007758 · Cited by 693 · see citing works

Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells

Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683 · see citing works

Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's Disease

Volles, M. J., Lee, S., Rochet, J., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682 · see citing works

Pathological implications of nitric oxide, superoxide and peroxynitrite formation

Beckman, J. S., & Crow, J. P. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210330 · Cited by 676 · see citing works

α-Synuclein misfolding and Parkinson's disease

Breydo, L., Wu, J., & Uversky, V. N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 656 · see citing works

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 652 · see citing works

Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

Martínez‐Vicente, M., Tallóczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J. R., Mosharov, E. V., Hodara, R., Fredenburg, R. A., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 633 · see citing works

Formation and Properties of Peroxynitrite as Studied by Laser Flash Photolysis, High-Pressure Stopped-Flow Technique, and Pulse Radiolysis

Kissner, R., Nauser, T., Bugnon, P., Lye, P. G., & Koppenol, W. H. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970160x · Cited by 629 · see citing works

Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation

Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 628 · see citing works

Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦

Nakamura, K., Nemani, V., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L. A., Zhang, J., Gardner, B. M., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 590 · see citing works

α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M. A., Ikeda, S.-I., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0098fje · Cited by 590 · see citing works

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

Fauvet, B., Mbefo, M. K., Fares, M.-B., Desobry, C., Michael, S. A., Ardah, M. T., Tsika, E., Coune, P., Prudent, M., Lion, N., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.318949 · Cited by 565 · see citing works

Dityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers

Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M. ‐., & Ischiropoulos, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000206200 · Cited by 561 · see citing works

Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease

Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Seubert, P., Lee, M., Goldstein, J., Chilcote, T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.010 · Cited by 542 · see citing works

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease

Tokuda, T., Qureshi, M. M., Ardah, M. T., Varghese, S., Shehab, S. A. S., Kasai, T., Ishigami, N., Tamaoka, A., Nakagawa, M., & El‐Agnaf, O. M. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd613b · Cited by 526 · see citing works

Lipid Rafts Mediate the Synaptic Localization of α-Synuclein

Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S., Anthony, M. D., & Edwards, R. H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1594-04.2004 · Cited by 518 · see citing works

Rapid reaction between peroxonitrite ion and carbon dioxide: Implications for biological activity

Lymar, S. V., & Hurst, J. K. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00139a027 · Cited by 515 · see citing works

�ber die Katalyse des Hydroperoxydes

Haber, F., & Weiss, J. (1932) · Die Naturwissenschaften · doi:10.1007/bf01504715 · Cited by 513 · see citing works

Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson's Disease Mutation

Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, C. G., & Goedert, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26292 · Cited by 512 · see citing works

Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin

Exner, N., Treske, B., Paquet, D., Holmström, K. M., Schiesling, C., Gispert, S., Carballo‐Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 511 · see citing works

Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1

Kamp, F., Exner, N., Lutz, A., Wender, N., Hegermann, J., Brunner, B., Nuscher, B., Bartels, T., Giese, A., Beyer, K., et al. (2010) · EMBO Journal · doi:10.1038/emboj.2010.223 · Cited by 505 · see citing works

The Aggregation and Fibrillation of α-Synuclein

Fink, A. L. (2006) · Accounts of Chemical Research · doi:10.1021/ar050073t · Cited by 503 · see citing works

Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement

Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S., & Langen, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807826105 · Cited by 501 · see citing works

Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures.

Galea, E., Feinstein, D. L., & Reis, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10945 · Cited by 478 · see citing works

The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils

Zhu, M., Rajamani, S., Kaylor, J. J., Han, S., Zhou, F., & Fink, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403129200 · Cited by 475 · see citing works

Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations

Li, W., West, N. C., Colla, E., Pletniková, O., Troncoso, J. C., Marsh, L., Dawson, T. M., Jäkälä, P., Hartmann, T., Price, D. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406976102 · Cited by 473 · see citing works

Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form

Lee, H.-J., Choi, C., & Lee, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107045200 · Cited by 452 · see citing works

Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration

Gao, H., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 435 · see citing works

Cellular Toxicity of Polyglutamine Expansion Proteins

Schaffar, G., Breuer, P., Boteva, R. N., Behrends, C., Tzvetkov, N., Strippel, N., Sakahira, H., Siegers, K., Hayer-Hartl, M. K., & Hartl, F. U. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.029 · Cited by 428 · see citing works

Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein

Willingham, S., Outeiro, T. F., DeVit, M. J., Lindquist, S. L., & Muchowski, P. J. (2003) · Science · doi:10.1126/science.1090389 · Cited by 422 · see citing works

Loss of Parkin or PINK1 Function Increases Drp1-dependent Mitochondrial Fragmentation*

Lutz, A., Exner, N., Fett, M. E., Schlehe, J. S., Kloos, K., Lämmermann, K., Brunner, B., Kurz-Drexler, A., Vogel, F., Reichert, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035774 · Cited by 421 · see citing works

Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405 · see citing works

Proteasomal Inhibition by α-Synuclein Filaments and Oligomers

Lindersson, E., Beedholm, R., Højrup, P., Moos, T., Gai, W., Hendil, K. B., & Jensen, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306390200 · Cited by 399 · see citing works

The reaction of NO· with O2·− and HO2·−: A pulse radiolysis study

Goldstein, S., & Czapski, G. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00034-u · Cited by 398 · see citing works

Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

Chu, Y., & Kordower, J. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.021 · Cited by 396 · see citing works

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

Reynolds, A. D., Stone, D. K., Hutter, J. A. L., Benner, E., Mosley, R., & Gendelman, H. E. (2010) · Journal of Immunology · doi:10.4049/jimmunol.0901852 · Cited by 391 · see citing works

An introduction to the free radical hypothesis in Parkinson's disease

Olanow, C. W. (1992) · Annals of Neurology · doi:10.1002/ana.410320703 · Cited by 382 · see citing works

Distinct RolesIn Vivofor the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-Synuclein

Ebrahimi‐Fakhari, D., Cantuti‐Castelvetri, I., Fan, Z., Rockenstein, E. M., Masliah, E., Hyman, B. T., McLean, P. J., & Unni, V. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1560-11.2011 · Cited by 378 · see citing works

Tyrosine Modification by Reactive Nitrogen Species: A Closer Look

Vandervliet, A., Eiserich, J. P., O’Neill, C., Halliwell, B. B., & Cross, C. E. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1303 · Cited by 373 · see citing works

Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease

Theodore, S., Cao, S., McLean, P. J., & Standaert, D. G. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e5e99 · Cited by 367 · see citing works

Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein

Paleologou, K. E., Schmid, A. W., Rospigliosi, C. C., Kim, H., Lamberto, G. R., Fredenburg, R. A., Lansbury, P. T., Fernández, C. O., Eliezer, D., Zweckstetter, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800747200 · Cited by 364 · see citing works

Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects

Borghi, R., Marchese, R., Negro, A., Marinelli, L., Forloni, G., Zaccheo, D., Abbruzzese, G., & Tabaton, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01153-8 · Cited by 363 · see citing works

Ubiquitination of α-Synuclein in Lewy Bodies Is a Pathological Event Not Associated with Impairment of Proteasome Function

Tofaris, G. K., Razzaq, A., Ghetti, B. F., Lilley, K. S., & Spillantini, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308041200 · Cited by 361 · see citing works

Structure of membrane-bound α-synuclein studied by site-directed spin labeling

Jao, C. C., Der-Sarkissian, A., Chen, J., & Langen, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400553101 · Cited by 360 · see citing works

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons

Benner, E. J., Banerjee, R., Reynolds, A. D., Sherman, S., Писарев, В. М., Tsiperson, V., Nemachek, C., Ciborowski, P. S., Przedborski, S., Mosley, R. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001376 · Cited by 359 · see citing works

Annular α-Synuclein Protofibrils Are Produced When Spherical Protofibrils Are Incubated in Solution or Bound to Brain-Derived Membranes

Ding, T. T., Lee, S., Rochet, J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020139h · Cited by 356 · see citing works

The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 356 · see citing works

A Pathologic Cascade Leading to Synaptic Dysfunction in -Synuclein-Induced Neurodegeneration

Scott, D. A., Tabarean, I. V., Tang, Y., Cartier, A. E., Masliah, E., & Roy, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1091-10.2010 · Cited by 353 · see citing works

Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy

Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D. S., & Stefanis, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005515 · Cited by 353 · see citing works

Lysosomal Degradation of α-Synuclein in Vivo

Mak, S. K., McCormack, A. L., Manning-Bog, A., Cuervo, A. M., & Monte, D. A. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074617 · Cited by 349 · see citing works

Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line

Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K., & Brundin, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205518200 · Cited by 349 · see citing works

Role of post-translational modifications in modulating the structure, function and toxicity of α-synuclein

Oueslati, A., Fournier, M., & Lashuel, H. A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83007-9 · Cited by 340 · see citing works

Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission

Bae, E.-J., Lee, H.-J., Rockenstein, E., Ho, D.-H., Park, E.-B., Yang, N.-Y., Desplats, P., Masliah, E., & Lee, S.-J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1292-12.2012 · Cited by 339 · see citing works

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2

Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W., et al. (2012) · Nature · doi:10.1038/nature11557 · Cited by 339 · see citing works

Reactions of nitrogen dioxide in aqueous model systems: Oxidation of tyrosine units in peptides and proteins

Prütz, W. A., Mönig, H., Butler, J., & Land, E. J. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90780-5 · Cited by 338 · see citing works

Mitochondrial association of alpha-synuclein causes oxidative stress

Parihar, M. S., Parihar, A., Fujita, M., Hashimoto, M., & Ghafourifar, P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7589-1 · Cited by 331 · see citing works

Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line

Scholz, D., Pöltl, D., Genewsky, A. J., Weng, M. K., Waldmann, T., Schildknecht, S., & Leist, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07255.x · Cited by 330 · see citing works

Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions

Paleologou, K. E., Oueslati, A., Shakked, G., Rospigliosi, C. C., Kim, H., Lamberto, G. R., Fernández, C. O., Schmid, A. W., Chegini, F., Gai, W., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5922-09.2010 · Cited by 324 · see citing works

Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein

Uversky, V. N., & Eliezer, D. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309789351921 · Cited by 320 · see citing works

Role of α-Synuclein in Presynaptic Dopamine Recruitment

Yavich, L., Tanila, H., Vepsäläinen, S., & Jäkälä, P. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2559-04.2004 · Cited by 316 · see citing works

Factors Determining the Selectivity of Protein Tyrosine Nitration

Souza, J. M., Daikhin, E., Yudkoff, M., Raman, C. S., & Ischiropoulos, H. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1480 · Cited by 315 · see citing works

Lipid Binding Inhibits α-Synuclein Fibril Formation

Zhu, M., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210136200 · Cited by 314 · see citing works

Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology

Danzer, K. M., Krebs, S. K., Wolff, M., Birk, G., & Hengerer, B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06324.x · Cited by 303 · see citing works

Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy

Yang, Q., She, H., Gearing, M., Colla, E., Lee, M. K., Shacka, J. J., & Mao, Z. (2009) · Science · doi:10.1126/science.1166088 · Cited by 302 · see citing works

Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases

Moskovitz, J. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.09.003 · Cited by 302 · see citing works

Direct EPR Detection of the Carbonate Radical Anion Produced from Peroxynitrite and Carbon Dioxide

Bonini, M. G., Radi, R., Ferrer-Sueta, G., Ferreira, A. M. D. C., & Augusto, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10802 · Cited by 293 · see citing works

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease

Garcia-Reitboeck, P., Anichtchik, O. V., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., Ghetti, B. F., Corte, L., Spano, P., Tofaris, G. K., et al. (2010) · Brain · doi:10.1093/brain/awq132 · Cited by 293 · see citing works

Functional Consequences of α-Synuclein Tyrosine Nitration

Hodara, R., Norris, E. H., Giasson, B. I., Mishizen-Eberz, A. J., Lynch, D. R., Lee, V. M. ‐., & Ischiropoulos, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408906200 · Cited by 286 · see citing works

Acceleration of Peroxynitrite Oxidations by Carbon Dioxide

Uppu, R. M., Squadrito, G. L., & Pryor, W. A. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0131 · Cited by 279 · see citing works

Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies

Duda, J. E., Giasson, B. I., Chen, Q., Gur, T., Hurtig, H. I., Stern, M. B., Gollomp, S. M., Ischiropoulos, H., Lee, V. M. ‐., & Trojanowski, J. Q. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64781-5 · Cited by 276 · see citing works

Microglial Activation and Dopaminergic Cell Injury: AnIn VitroModel Relevant to Parkinson's Disease

Le, W. D., Rowe, D. B., Xie, W., Ortiz, I., He, Y., & Appel, S. H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08447.2001 · Cited by 274 · see citing works

Reversible Inhibition of α-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations

Norris, E. H., Giasson, B. I., Hodara, R., Xu, S., Trojanowski, J. Q., Ischiropoulos, H., & Lee, V. M.-Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412621200 · Cited by 273 · see citing works

Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons

Stefanova, N., Fellner, L., Reindl, M., Masliah, E., Poewe, W., & Wenning, G. K. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.013 · Cited by 272 · see citing works

α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1

Lee, E.-J., Woo, M.-S., Moon, P., Baek, M., Choi, I.-Y., Kim, W.-K., Junn, E., & Kim, H.-S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903480 · Cited by 267 · see citing works

Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway

Lotharius, J., Falsig, J., van Beek, J., Payne, S., Dringen, R., Brundin, P., & Leist, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1746-05.2005 · Cited by 262 · see citing works

Mitochondrial Lipid Abnormality and Electron Transport Chain Impairment in Mice Lacking α-Synuclein

Ellis, C. E., Murphy, E. J., Mitchell, D. C., Golovko, M. Y., Scaglia, F., Barceló‐Coblijn, G., & Nussbaum, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10190-10201.2005 · Cited by 260 · see citing works

Dopamine and L‐dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease

Li, J., Zhu, M., Manning-Bog, A., Monte, D. A. D., & Fink, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0770fje · Cited by 257 · see citing works

Dopamine promotes α‐synuclein aggregation into SDS‐resistant soluble oligomers via a distinct folding pathway

Cappai, R., Leck, S., Tew, D. J., Williamson, N. A., Smith, D. P., Galatis, D., Sharpies, R. A., Curtain, C. C., Ali, F. E. A., Cherny, R. A., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3437fje · Cited by 254 · see citing works

α-Synuclein Has a High Affinity for Packing Defects in a Bilayer Membrane

Nuscher, B., Kamp, F., Mehnert, T., Odoy, S., Haass, C., Kahle, P. J., & Beyer, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401076200 · Cited by 251 · see citing works

Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease

Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., Ciborowski, P. S., Cerny, R. L., Gelman, B. B., Thomas, M. P., Mosley, R. L., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 244 · see citing works

Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein immunocytochemistry

Braak, H., Sandmann-Keil, D., Gai, W., & Braak, E. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00208-6 · Cited by 242 · see citing works

Proteolytic Cleavage of Extracellular Secreted α-Synuclein via Matrix Metalloproteinases

Sung, J. Y., Park, S., Lee, C.-H., Um, J. W., Lee, H. J., Kim, J., Oh, Y. J., Lee, S., Paik, S. R., & Chung, K. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503341200 · Cited by 238 · see citing works

Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase

Chéret, C., Gervais, A., Lelli, A., Colin, C., Amar, L., Ravassard, P., Mallet, J., Cumano, A., Krause, K.-H., & Mallat, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3568-08.2008 · Cited by 225 · see citing works

Methionine oxidation inhibits fibrillation of human α‐synuclein in vitro

Uversky, V. N., Yamin, G., Souillac, P. O., Goers, J. W. F., Glaser, C. B., & Fink, A. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02638-8 · Cited by 222 · see citing works

Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties

Maltsev, A. S., Ying, J., & Bax, A. (2012) · Biochemistry · doi:10.1021/bi300642h · Cited by 217 · see citing works

Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease

Li, J., Englund, E. M., Widner, H., Rehncrona, S., Björklund, A., Lindvall, O., & Brundin, P. (2010) · Movement Disorders · doi:10.1002/mds.23012 · Cited by 214 · see citing works

Protein tyrosine nitration—An update

Ischiropoulos, H. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.10.034 · Cited by 207 · see citing works

Oxidative stress as a cause of Parkinson's disease

Jenner, P. G., & Jenner, P. G. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05013.x · Cited by 205 · see citing works

Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family

Anwar, S., Peters, O. M., Millership, S. J., Ninkina, N. N., Doig, N. M., Connor‐Robson, N., Threlfell, S., Kooner, G., Deacon, R. M. J., Bannerman, D. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6194-10.2011 · Cited by 200 · see citing works

A Combinatorial Code for the Interaction of α-Synuclein with Membranes

Kubo, S., Nemani, V. M., Chalkley, R. J., Anthony, M. D., Hattori, N., Mizuno, Y., Edwards, R. H., & Fortin, D. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504894200 · Cited by 197 · see citing works

Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets

Reynolds, A. D., Stone, D. K., Mosley, R. L., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803982 · Cited by 197 · see citing works

Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation

Qin, Z., Hu, D., Han, S., Reaney, S. H., Monte, D. A. D., & Fink, A. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608126200 · Cited by 193 · see citing works

Stabilization of Partially Folded Conformation during α-Synuclein Oligomerization in Both Purified and Cytosolic Preparations

Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186 · see citing works

Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture

Giulian, D., Li, J., Leara, B., & Keenen, C. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90066-3 · Cited by 181 · see citing works

Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation

Li, W., Lesuisse, C., Xu, Y., Troncoso, J. C., Price, D. L., & Lee, M. K. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1370-04.2004 · Cited by 178 · see citing works

Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation

Yermolaieva, O., Xu, R., Schinstock, C. A., Brot, N., Weissbach, H., Heinemann, S. H., & Hoshi, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308215100 · Cited by 174 · see citing works

Membrane Binding and Self-Association of α-Synucleins

Narayanan, V. S., & Scarlata, S. (2001) · Biochemistry · doi:10.1021/bi002952n · Cited by 170 · see citing works

Characterization of Semisynthetic and Naturally Nα-Acetylated α-Synuclein in Vitro and in Intact Cells

Fauvet, B., Fares, M.-B., Samuel, F., Dikiy, I., Tandon, A., Eliezer, D., & Lashuel, H. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383711 · Cited by 169 · see citing works

The sour side of neurodegenerative disorders: the effects of protein glycation

Miranda, H. V., & Outeiro, T. F. (2009) · The Journal of Pathology · doi:10.1002/path.2682 · Cited by 168 · see citing works

Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers

Yamin, G., Uversky, V. N., & Fink, A. L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00367-3 · Cited by 167 · see citing works

Characterization of Oligomeric Intermediates in α-Synuclein Fibrillation: FRET Studies of Y125W/Y133F/Y136F α-Synuclein

Kaylor, J. J., Bodner, N., Edridge, S., Yamin, G., Hong, D.-P., & Fink, A. L. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.046 · Cited by 159 · see citing works

Dityrosine Formation Outcompetes Tyrosine Nitration at Low Steady-state Concentrations of Peroxynitrite

Pfeiffer, S., Schmidt, K., & Mayer, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6346 · Cited by 158 · see citing works

α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra

McCormack, A. L., Mak, S. K., Henderson, J. M., Bumcrot, D. A., Farrer, M. J., & Monte, D. A. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012122 · Cited by 158 · see citing works

Effects of nitration on the structure and aggregation of α-synuclein

Uversky, V. N., Yamin, G., Munishkina, L. A., Karymov, M. A., Millett, I. S., Doniach, S., Lyubchenko, Y. L., & Fink, A. L. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.014 · Cited by 157 · see citing works

Genetics of Parkinson's disease

Nussbaum, R. L. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1687 · Cited by 155 · see citing works

The First N-terminal Amino Acids of α-Synuclein Are Essential for α-Helical Structure Formation In Vitro and Membrane Binding in Yeast

Vamvaca, K., Volles, M. J., & Lansbury, P. T. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.021 · Cited by 149 · see citing works

In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age

Fornstedt, B., Pileblad, E., & Carlsson, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04183.x · Cited by 143 · see citing works

Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity

Giovanni, S. D., Eleuteri, S., Paleologou, K. E., Yin, G., Zweckstetter, M., Carrupt, P., & Lashuel, H. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080390 · Cited by 137 · see citing works

Allostery in a Disordered Protein: Oxidative Modifications to α-Synuclein Act Distally To Regulate Membrane Binding

Sevcsik, E., Trexler, A., Dunn, J. M., & Rhoades, E. R. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2009554 · Cited by 133 · see citing works

The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties

Näsström, T., Fagerqvist, T., Barbu, M., Karlsson, M., Nikolajeff, F. K., Kasrayan, A., Ekberg, M., Lannfelt, L., Ingelsson, M., & Bergström, J. J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.027 · Cited by 131 · see citing works

Towards Elucidation of the Role of Ubiquitination in the Pathogenesis of Parkinson’s Disease with Semisynthetic Ubiquitinated α‐Synuclein

Hejjaoui, M., Haj‐Yahya, M., Kumar, K. S. A., Brik, A., & Lashuel, H. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005546 · Cited by 129 · see citing works

Genetic Analysis of Families with Parkinson Disease that Carry the Ala53Thr Mutation in the Gene Encoding α-Synuclein

Athanassiadou, A., Voutsinas, G. E., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A., Maniatis, G. M., & Papapetropoulos, T. (1999) · The American Journal of Human Genetics · doi:10.1086/302486 · Cited by 128 · see citing works

Lipid Peroxidation Product 4-Hydroxy-2-Nonenal Promotes Seeding-Capable Oligomer Formation and Cell-to-Cell Transfer of α-Synuclein

Bae, E.-J., Ho, D. H., Park, E., Jung, J. W., Cho, K., Hong, J. H., Lee, H.-J., Kim, K. P., & Lee, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4429 · Cited by 126 · see citing works

Methionine Sulfoxide Reductase A and a Dietary Supplement S -Methyl- L -Cysteine Prevent Parkinson's-Like Symptoms

Wassef, R., Haenold, R., Hansel, A., Brot, N., Heinemann, S. H., & Hoshi, T. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0322-07.2007 · Cited by 123 · see citing works

Preferentially Increased Nitration of α-Synuclein at Tyrosine-39 in a Cellular Oxidative Model of Parkinson’s Disease

Danielson, S. R., Held, J. M., Schilling, B., Oo, M. L., Gibson, B. W., & Andersen, J. K. (2009) · Analytical Chemistry · doi:10.1021/ac901176t · Cited by 123 · see citing works

Binding of α-Synuclein Affects the Lipid Packing in Bilayers of Small Vesicles

Kamp, F., & Beyer, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512292200 · Cited by 122 · see citing works

On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation

Arriagada, C., Paris, I. B., Matas, M. J. S. D. L., Martinez-Alvarado, P., Cárdenas, S., Castañeda, P., Graumann, R., Perez-Pastene, C., Olea‐Azar, C., Couve, E., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.014 · Cited by 120 · see citing works

Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region

Herrera, F. E., Chesi, A., Paleologou, K. E., Schmid, A. W., Munoz, A., Vendruscolo, M., Gustincich, S., Lashuel, H. A., & Carloni, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003394 · Cited by 119 · see citing works

Cleavage of α-Synuclein by Calpain: Potential Role in Degradation of Fibrillized and Nitrated Species of α-Synuclein

Mishizen-Eberz, A. J., Norris, E. H., Giasson, B. I., Hodara, R., Ischiropoulos, H., Lee, V. M. ‐., Trojanowski, J. Q., & Lynch, D. R. (2005) · Biochemistry · doi:10.1021/bi047846q · Cited by 117 · see citing works

Metal-catalyzed Oxidation of α-Synuclein

Cole, N. B., Murphy, D. D., Lebowitz, J., Noto, L. D., Levine, R. L., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409946200 · Cited by 117 · see citing works

The Transgenic Overexpression of α-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition

Loeb, V., Yakunin, E., Saada, A., & Sharon, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061051 · Cited by 115 · see citing works

Elucidating the Role of C-Terminal Post-Translational Modifications Using Protein Semisynthesis Strategies: α-Synuclein Phosphorylation at Tyrosine 125

Hejjaoui, M., Butterfield, S. M., Fauvet, B., Vercruysse, F., Cui, J., Dikiy, I., Prudent, M., Olschewski, D., Zhang, Y., Eliezer, D., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210866j · Cited by 115 · see citing works

Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation

Leong, S. L., Pham, C. L. L., Galatis, D., Fodero‐Tavoletti, M. T., Perez, K. A., Hill, A. F., Masters, C. L., Ali, F. E. A., Barnham, K. J., & Cappai, R. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.009 · Cited by 114 · see citing works

Ubiquitination of α-synuclein and autophagy in Parkinson's disease

Engelender, S. (2008) · Autophagy · doi:10.4161/auto.5604 · Cited by 114 · see citing works

Peroxynitrous Acid Homolyzes into •OH and •NO2 Radicals

Merényi, G., Lind, J., Goldstein, S., & Czapski, G. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980043h · Cited by 112 · see citing works

Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology

Ulusoy, A., Febbraro, F., Jensen, P. H., Kirik, D., & Romero‐Ramos, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07284.x · Cited by 111 · see citing works

Remodeling of Lipid Vesicles into Cylindrical Micelles by α-Synuclein in an Extended α-Helical Conformation

Mizuno, N., Varkey, J., Kegulian, N. C., Hegde, B. G., Cheng, N., Langen, R., & Steven, A. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365817 · Cited by 109 · see citing works

Neuroprotection by Minocycline Caused by Direct and Specific Scavenging of Peroxynitrite

Schildknecht, S., Pape, R., Müller, N., Robotta, M., Marquardt, A., Bürkle, A., Drescher, M., & Leist, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169565 · Cited by 107 · see citing works

Controlling the mass action of α‐synuclein in Parkinson’s disease

Kim, C., & Lee, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05612.x · Cited by 105 · see citing works

Mechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane

Beyer, K. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0014-9 · Cited by 104 · see citing works

Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults

Liu, F., Hindupur, J., Nguyen, J. L., Ruf, K. J., Zhu, J., Schieler, J. L., Bonham, C. C., Wood, K. V., Davisson, V. J., & Rochet, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.022 · Cited by 102 · see citing works

Methionine oxidation stabilizes non-toxic oligomers of α-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions

Zhou, W., Long, C., Reaney, S. H., Monte, D. A. D., Fink, A. L., & Uversky, V. N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.004 · Cited by 101 · see citing works

A novel molecular mechanism for nitrated α-synuclein-induced cell death

Liu, Y., Qiang, M., Wei, Y., & He, R. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr011 · Cited by 96 · see citing works

Role of Individual Methionines in the Fibrillation of Methionine-Oxidized α-Synuclein

Hokenson, M. J., Uversky, V. N., Goers, J. W. F., Yamin, G., Munishkina, L. A., & Fink, A. L. (2004) · Biochemistry · doi:10.1021/bi049979h · Cited by 95 · see citing works

Dopamine quinones interact with α-synuclein to form unstructured adducts

Bisaglia, M., Tosatto, L., Munari, F., Tessari, I., de Laureto, P. P., Mammi, S., & Bubacco, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.044 · Cited by 93 · see citing works

Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States

Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242 · see citing works

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,120 · see citing works

Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)

Theillet, F., Binolfi, A., Frembgen-Kesner, T., Hingorani, K. S., Sarkar, M., Kyne, C., Li, C., Crowley, P. B., Gierasch, L. M., Pielak, G. J., et al. (2014) · Chemical Reviews · doi:10.1021/cr400695p · Cited by 504 · see citing works

Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription

Ryan, S. D., Dolatabadi, N., Chan, S. F., Zhang, X., Akhtar, M. W., Parker, J., Soldner, F., Sunico, C. R., Nagar, S., Talantova, M. V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.009 · Cited by 430 · see citing works

Oxidative stress and regulated cell death in Parkinson’s disease

Dionísio, P. A., Amaral, J. D., & Rodrigues, C. M. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101263 · Cited by 436 · see citing works

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease

Ganguly, G., Chakrabarti, S., Chatterjee, U., & Saso, L. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s130514 · Cited by 295 · see citing works

Endoplasmic reticulum stress and inflammation in the central nervous system

Sprenkle, N. T., Sims, S. G., Sánchez, C. L., & Meares, G. P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0183-y · Cited by 299 · see citing works

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies

Hatano, T., Saiki, S., Okuzumi, A., Mohney, R., & Hattori, N. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309676 · Cited by 257 · see citing works

Inflammation is genetically implicated in Parkinson’s disease

Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222 · see citing works

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

Weihofen, A., Liu, Y., Arndt, J. W., Huy, C., Quan, C., Smith, B. A., Baeriswyl, J., Cavegn, N., Senn, L., Su, L., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.016 · Cited by 195 · see citing works

Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer

Musgrove, R. E., Helwig, M., Bae, E.-J., Aboutalebi, H., Lee, S., Ulusoy, A., & Monte, D. A. D. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127330 · Cited by 189 · see citing works

Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress

Akbar, M. D., Essa, M. M., Daradkeh, G., Abdelmegeed, M. A., Choi, Y., Mahmood, L., & Song, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.016 · Cited by 176 · see citing works

Heat shock proteins as potential targets for protective strategies in neurodegeneration

Kampinga, H. H., & Bergink, S. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00099-5 · Cited by 172 · see citing works

Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson’s Disease via Protein Semisynthesis and Mutagenesis

Burai, R., Ait‐Bouziad, N., Chiki, A., & Lashuel, H. A. (2015) · Journal of the American Chemical Society · doi:10.1021/ja5131726 · Cited by 161 · see citing works

The cell biology of Parkinson’s disease

Panicker, N., Ge, P., Dawson, V. L., & Dawson, T. M. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202012095 · Cited by 164 · see citing works

Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease

Lim, C. K., Fernández-Gomez, F. J., Braidy, N., Estrada, C., Costa, C., Costa, S., Bessede, A., Fernandez-Villalba, E., Zinger, A., Herrero, M. T., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.009 · Cited by 159 · see citing works

Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation

Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156 · see citing works

The role of neuroimaging in Parkinson’s disease

Bidesi, N., Andersen, I. V., Windhorst, A. D., Shalgunov, V., & Herth, M. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15516 · Cited by 147 · see citing works

Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease

Dumitriu, A., Golji, J., Labadorf, A. T., Gao, B., Beach, T. G., Myers, R. H., Longo, K. A., & Latourelle, J. C. (2015) · BMC Medical Genomics · doi:10.1186/s12920-016-0164-y · Cited by 129 · see citing works

Neuropathology of α‐synuclein propagation and braak hypothesis

McCann, H., Cartwright, H., & Halliday, G. M. (2015) · Movement Disorders · doi:10.1002/mds.26421 · Cited by 132 · see citing works

Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging

Gonos, E. S., Καπετάνου, Μ., Sereikaitė, J., Bartosz, G., Naparło, K., Grzesik, M., & Sadowska‐Bartosz, I. (2018) · Aging · doi:10.18632/aging.101450 · Cited by 133 · see citing works

An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition

Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124 · see citing works

Mechanisms of Metal-Induced Mitochondrial Dysfunction in Neurological Disorders

Cheng, H., Yang, B., Ke, T., Li, S., Yang, X., Aschner, M., & Chen, P. (2021) · Toxics · doi:10.3390/toxics9060142 · Cited by 116 · see citing works

The Proteasome Inhibition Model of Parkinson’s Disease

Bentea, E., Verbruggen, L., & Massie, A. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160921 · Cited by 111 · see citing works

Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites

Binolfi, A., Limatola, A., Verzini, S., Kosten, J., Theillet, F., Rose, H. M., Bekei, B., Stuiver, M., van Rossum, M., & Selenko, P. (2016) · Nature Communications · doi:10.1038/ncomms10251 · Cited by 105 · see citing works

Interactions between iron and α-synuclein pathology in Parkinson's disease

Chen, B., Wen, X., Jiang, H. F., Wang, J., Song, N., & Xie, J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.024 · Cited by 103 · see citing works

Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP

Schildknecht, S., Monte, D. A. D., Pape, R., Tieu, K., & Leist, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.03.010 · Cited by 96 · see citing works

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model

Chatterjee, D., Bhatt, M. A., Butler, D., Genst, E. D., Dobson, C. M., Messer, A. C., & Kordower, J. H. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0062-4 · Cited by 93 · see citing works

Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders

Messer, A. C., & Butler, D. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104619 · Cited by 91 · see citing works

Alpha‐Synuclein Binds to the Inner Membrane of Mitochondria in an α‐Helical Conformation

Robotta, M., Gerding, H. R., Vogel, A., Hauser, K., Schildknecht, S., Karreman, C., Leist, M., Subramaniam, V., & Drescher, M. (2014) · ChemBioChem · doi:10.1002/cbic.201402281 · Cited by 91 · see citing works

Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases

Schildknecht, S. (2013) · ALTEX · doi:10.14573/altex.2013.4.427 · Cited by 85 · see citing works

Selective neuronal vulnerability in Parkinson's disease

González‐Rodríguez, P., Zampese, E., & Surmeier, D. J. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.02.005 · Cited by 75 · see citing works

Site-Specific Copper-Catalyzed Oxidation of α-Synuclein: Tightening the Link between Metal Binding and Protein Oxidative Damage in Parkinson’s Disease

Miotto, M., Rodríguez, E. E., Valiente‐Gabioud, A. A., Monserrat, V. T., Binolfi, A., Quintanar, L., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2014) · Inorganic Chemistry · doi:10.1021/ic4031377 · Cited by 77 · see citing works

α-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration

Fecchio, C., Palazzi, L., & de Laureto, P. P. (2018) · Molecules · doi:10.3390/molecules23071531 · Cited by 70 · see citing works

Chemical modification of pro-inflammatory proteins by peroxynitrite increases activation of TLR4 and NF-κB: Implications for the health effects of air pollution and oxidative stress

Ziegler, K., Kunert, A. T., Reinmuth-Selzle, K., Leifke, A. L., Widera, D., Weller, M. G., Schuppan, D., Fröhlich‐Nowoisky, J., Lucas, K., & Pöschl, U. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101581 · Cited by 65 · see citing works

An Update on the Critical Role of α-Synuclein in Parkinson’s Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels

Serratos, I. N., Hernández‐Pérez, E., Campos, C., Aschner, M., & Santamarı́a, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02596-3 · Cited by 64 · see citing works

Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders

Donatti, A., do Canto, A. M., Godoi, A. B., da Rosa, D. C., & Lopes‐Cendes, Í. (2020) · Metabolites · doi:10.3390/metabo10100389 · Cited by 64 · see citing works

Functional Roles of Protein Nitration in Acute and Chronic Liver Diseases

Abdelmegeed, M. A., & Song, B. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/149627 · Cited by 61 · see citing works

Coordination and redox properties of copper interaction with α-synuclein

Valensin, D., Dell’Acqua, S., Kozłowski, H., & Casella, L. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.012 · Cited by 61 · see citing works

C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease

Kleinknecht, A., Popova, B., Lázaro, D. F., Pinho, R., Valerius, O., Outeiro, T. F., & Braus, G. H. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006098 · Cited by 61 · see citing works

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Wu, J., Wu, J., Chen, T., Cai, J., & Ren, R. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105880 · Cited by 61 · see citing works

NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice

Anandhan, A., Nguyen, N., Syal, A., Dreher, L. A., Dodson, M. B., Zhang, D. D., & Madhavan, L. (2021) · Aging and Disease · doi:10.14336/ad.2021.0511 · Cited by 59 · see citing works

Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties

Marchiani, A., Mammi, S., Siligardi, G., Hussain, R., Tessari, I., Bubacco, L., Delogu, G., Fabbri, D., Dettori, M. A., Sanna, D., et al. (2013) · Amino Acids · doi:10.1007/s00726-013-1503-3 · Cited by 59 · see citing works

Molecular Imaging Insights into Neurodegeneration: Focus on α-Synuclein Radiotracers

Shah, M., Seibyl, J. P., Cartier, A. E., Bhatt, R., & Catafau, A. M. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.136515 · Cited by 57 · see citing works

Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach

Toni, M., Massimino, M. L., Mario, A. D., Angiulli, E., & Spisni, E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00003 · Cited by 55 · see citing works

Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease

Calahorra, J., de la Riva, M. P., Martínez‐Lara, E., Siles, E., & Cañuelo, A. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.003 · Cited by 57 · see citing works

Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α‐Synuclein

Werner‐Allen, J. W., DuMond, J. F., Levine, R. L., & Bax, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201600277 · Cited by 56 · see citing works

Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease

Stykel, M. G., Humphries, K. M., Kirby, M. P., Czaniecki, C., Wang, T., Ryan, T. L., Bamm, V. V., & Ryan, S. D. (2018) · The FASEB Journal · doi:10.1096/fj.201700759rr · Cited by 56 · see citing works

Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment

Maki, R. A., Holzer, M., Motamedchaboki, K., Malle, E., Masliah, E., Marsche, G., & Reynolds, W. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.033 · Cited by 56 · see citing works

The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite

Schildknecht, S., Weber, A., Gerding, H., Pape, R., Robotta, M., Drescher, M., Marquardt, A., Daiber, A., Ferger, B., & Leist, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990179 · Cited by 55 · see citing works

Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases

Hassanzadeh, K., Liu, J., Maddila, S. C., & Mouradian, M. M. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001111 · Cited by 53 · see citing works

GYY4137, an H2S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson’s Disease

Hou, X., Yuan, Y., Sheng, Y., Yuan, B., Wang, Y., Zheng, J., Liu, C., Zhang, X., & Hu, L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00741 · Cited by 53 · see citing works

Excessive levels of nitric oxide in rat model of Parkinson’s disease induced by rotenone

Xiong, Z.-K., Lang, J., Xu, G., LI, H.-Y., Zhang, Y., Wang, L., SU, Y., & SUN, A.-J. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2099 · Cited by 52 · see citing works

Animal use for science in Europe

Daneshian, M. (2015) · ALTEX · doi:10.14573/altex.1509081 · Cited by 52 · see citing works

Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia†

(PPR), E. P. O. P. P. P. A. T. R., Ockleford, C., Adriaanse, P., Berny, P. J., Brock, T. C. M., Duquesne, S., Grilli, S., Hernández, A. F., Bennekou, S. H., Klein, M., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4691 · Cited by 51 · see citing works

Revisiting the neuropathogenesis of Zellweger syndrome

Crane, D. I. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.02.007 · Cited by 51 · see citing works

Reactivity of copper–α-synuclein peptide complexes relevant to Parkinson’s disease

Dell’Acqua, S., Pirota, V., Anzani, C., Rocco, M. M., Nicolis, S., Valensin, D., Monzani, E., & Casella, L. (2015) · Metallomics · doi:10.1039/c4mt00345d · Cited by 51 · see citing works

Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson’s Disease

McCarty, M. F., & Lerner, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103624 · Cited by 51 · see citing works

Crosstalk between Oxidative Stress and Inflammation Caused by Noise and Air Pollution—Implications for Neurodegenerative Diseases

Kuntić, M., Hahad, O., Münzel, T. F., & Daiber, A. (2024) · Antioxidants · doi:10.3390/antiox13030266 · Cited by 50 · see citing works

Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein

Tyson, T., Senchuk, M. M., Cooper, J. F., George, S., Raamsdonk, J. M. V., & Brundin, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-07383-6 · Cited by 43 · see citing works

Mechanisms of aging-related proteinopathies in Caenorhabditis elegans

Kim, D., Kim, T. H., & Lee, S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.109 · Cited by 42 · see citing works

Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure

Ponzini, E., Palma, A. D., Cerboni, L., Natalello, A., Rossi, R., Moons, R., Konijnenberg, A., Narkiewicz, J., Legname, G., Sobott, F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001907 · Cited by 42 · see citing works

Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants

Gutbier, S., Kyriakou, S., Schildknecht, S., Ückert, A., Brüll, M., Lewis, F. W., Dickens, D., Pearson, L. T., Elson, J. L., Michel, S., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02826-y · Cited by 42 · see citing works

Oxidative Stress and Mitochondrial Complex I Dysfunction Correlate with Neurodegeneration in an α-Synucleinopathy Animal Model

Morales-Martínez, A., Martínez-Gómez, P. A., Martínez‐Fong, D., Villegas-Rojas, M. M., Pérez‐Severiano, F., Toro-Colín, M. A. D., Delgado-Minjares, K. M., Blanco-Álvarez, V. M., León‐Chávez, B. A., Aparicio‐Trejo, O. E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911394 · Cited by 42 · see citing works

Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease

Lucchesi, M., Biso, L., Bonaso, M., Longoni, B., Buchignani, B., Battini, R., Santorelli, F. M., Doccini, S., & Scarselli, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094451 · Cited by 39 · see citing works

Chemiexcitation and Its Implications for Disease

Brash, D. E., Gonçalves, L. C. P., & Bechara, E. J. H. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.004 · Cited by 36 · see citing works

Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies

Brüll, M. (2020) · ALTEX · doi:10.14573/altex.1911111 · Cited by 42 · see citing works

α-Synuclein structural features inhibit harmful polyunsaturated fatty acid oxidation, suggesting roles in neuroprotection

Franceschi, G. D., Fecchio, C., Sharon, R., Schapira, A. H. V., Proukakis, C., Bellotti, V., & de Laureto, P. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.765149 · Cited by 36 · see citing works

Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreading

Helwig, M., Ulusoy, A., Rollar, A., O’Sullivan, S. A., Lee, S. S. L., Aboutalebi, H., Pinto‐Costa, R., Jevans, B., Klinkenberg, M., & Monte, D. A. D. (2022) · Science Advances · doi:10.1126/sciadv.abn0356 · Cited by 36 · see citing works

Reductive modification of genetically encoded 3-nitrotyrosine sites in alpha synuclein expressed in E.coli

Gerding, H. R., Karreman, C., Daiber, A., Delp, J., Hammler, D., Mex, M., Schildknecht, S., & Leist, M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101251 · Cited by 31 · see citing works

Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson’s disease

Sharma, S., & Priya, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2340-9 · Cited by 31 · see citing works

Selective Affinity Enrichment of Nitrotyrosine-Containing Peptides for Quantitative Analysis in Complex Samples

Zhao, Y., Zhang, Y., Sun, H., Maroto, R., & Brasier, A. R. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00275 · Cited by 28 · see citing works

Universal Nature-Inspired Coatings for Preparing Noncharging Surfaces

Fang, Y., Gonuguntla, S., & Soh, S. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07711 · Cited by 29 · see citing works

Targeted de-repression of neuronal Nrf2 inhibits α-synuclein accumulation

Baxter, P. S., Márkus, N. M., Dando, O., He, X., Al-Mubarak, B. R., Qiu, J., & Hardingham, G. E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03507-z · Cited by 29 · see citing works

Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures

Bennett, J. P., & Onyango, I. G. (2021) · Biomedicines · doi:10.3390/biomedicines9020225 · Cited by 28 · see citing works

Progress toward an integrated understanding of Parkinson’s disease

Rousseaux, M. W. C., Shulman, J. M., & Jankovic, J. J. (2017) · F1000Research · doi:10.12688/f1000research.11820.1 · Cited by 27 · see citing works

Correlation of structural features of novel 1,2,3-triazoles with their neurotoxic and tumoricidal properties

de Souza-Fagundes, E. M., Delp, J., Prazeres, P. H. D. M., Marques, L. B., Carmo, A. M. L., Stroppa, P. H. F., Glanzmann, N., Kisitu, J., Szamosvári, D., Böttcher, T., et al. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.06.029 · Cited by 27 · see citing works

Copper(I) Forms a Redox-Stable 1:2 Complex with α-Synuclein N-Terminal Peptide in a Membrane-Like Environment

Dell’Acqua, S., Pirota, V., Monzani, E., Camponeschi, F., Ricco, R. D., Valensin, D., & Casella, L. (2016) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.6b00641 · Cited by 27 · see citing works

G6PD deficiency triggers dopamine loss and the initiation of Parkinson’s disease pathogenesis

Stykel, M. G., Siripala, S. V., Soubeyrand, E., Coackley, C. L., Lu, P., Camargo, S., Thevasenan, S., Figueroa, G. B., So, R. W. L., Stuart, E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115178 · Cited by 25 · see citing works

Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience

Beaurain, M., Salabert, A., Ribeiro, M. J., Arlicot, N., Damier, P., Jeune, F. L., Démonet, J., & Payoux, P. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00268 · Cited by 26 · see citing works

Old wines in new bottles: Repurposing opportunities for Parkinson's disease

Kakkar, A. K., Singh, H., & Medhi, B. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.023 · Cited by 25 · see citing works

Metals in Alzheimer’s and Parkinson’s Disease: Relevance to Dementia with Lewy Bodies

McAllum, E. J., & Finkelstein, D. I. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0809-5 · Cited by 24 · see citing works

Inverse association between yerba mate consumption and idiopathic Parkinson's disease. A case–control study

Gatto, E. M., Melcon, C. M., Parisi, V. L., Bartoloni, L. C., & González, C. D. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.06.043 · Cited by 24 · see citing works

Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase

Vitola, P. L., Szegő, É. M., Pinto‐Costa, R., Rollar, A., Harbachova, E. L., Schapira, A. H. V., Ulusoy, A., & Monte, D. A. D. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00842-8 · Cited by 25 · see citing works

Cu2+, Ca2+, and methionine oxidation expose the hydrophobic α-synuclein NAC domain

Ramis, R., Ortega‐Castro, J., Vilanova, B., Adrover, M., & Frau, J. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.018 · Cited by 22 · see citing works

Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease

Church, T. R., & Margolis, S. S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1531797 · Cited by 24 · see citing works

Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein

Werner‐Allen, J. W., Monti, S., DuMond, J. F., Levine, R. L., & Bax, A. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01164 · Cited by 22 · see citing works

Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease

Yang, X., Zhao, H., Shi, H., Wang, X., Zhang, S., Zhang, Z., Zu, J., Zhang, W., Shen, X., Cui, G., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.007 · Cited by 21 · see citing works

Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson’s and other related neurodegenerative diseases

Riaz, Z., Richardson, G. S., Jin, H., Zenitsky, G. D., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00774-0 · Cited by 23 · see citing works

Nitration and Glycation Diminish the α-Synuclein Role in the Formation and Scavenging of Cu2+-Catalyzed Reactive Oxygen Species

Martínez-Orozco, H., Mariño, L., Uceda, A. B., Ortega‐Castro, J., Vilanova, B., Frau, J., & Adrover, M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00142 · Cited by 19 · see citing works

Small Molecules, α-Synuclein Pathology, and the Search for Effective Treatments in Parkinson’s Disease

Sechi, G., & Sechi, M. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011198 · Cited by 18 · see citing works

Reduced Aβ secretion by human neurons under conditions of strongly increased BACE activity

Scholz, D., Chernyshova, Y., Ückert, A., & Leist, M. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14467 · Cited by 18 · see citing works

Chemiexcitation: Mammalian Photochemistry in the Dark^†

Brash, D. E., & Goncalves, L. C. P. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13781 · Cited by 16 · see citing works

Novel anti-apoptotic L-DOPA precursors SuperDopa and SuperDopamide as potential neuroprotective agents for halting/delaying progression of Parkinson’s disease

Wiesen, T., & Atlas, D. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04667-2 · Cited by 17 · see citing works

Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk

Caproni, S., Fonzo, A. D., & Colosimo, C. (2025) · Parkinson s Disease · doi:10.1155/padi/6691390 · Cited by 15 · see citing works

Sirtuins and Proteolytic Systems: Implications for Pathogenesis of Synucleinopathies

Sampaio‐Marques, B., & Ludovico, P. (2015) · Biomolecules · doi:10.3390/biom5020735 · Cited by 14 · see citing works

The E3 ubiquitin ligase seven in absentia homolog 1 may be a potential new therapeutic target for Parkinson′s disease

Cai, Z., Xu, J., Xue, S.-R., Liu, Y.-Y., Zhang, Y., Zhang, X.-Z., Wang, X., Wu, F., & Li, X. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.162763 · Cited by 15 · see citing works

Gastric Enteric Glial Cells: A New Contributor to the Synucleinopathies in the MPTP-Induced Parkinsonism Mouse

Heng, Y., Li, Y., Wen, L., Yan, J., Chen, N., & Yuan, Y. (2022) · Molecules · doi:10.3390/molecules27217414 · Cited by 15 · see citing works

pH Effects Can Dominate Chemical Shift Perturbations in 1H,15N-HSQC NMR Spectroscopy for Studies of Small Molecule/α-Synuclein Interactions

Pandey, A. K., Buchholz, C. R., Kochen, N. N., Pomerantz, W. C. K., Braun, A. R., & Sachs, J. N. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00782 · Cited by 14 · see citing works

Post-translational modifications of alpha-synuclein protein by oxidative and nitrative stress mechanisms and their effects on the pathogenesis of synucleinopathies

Norris, E. H. (2004) · Scholarly Commons (University of Pennsylvania)

Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases

Chavarría, C., & Souza, J. M. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.02.009 · Cited by 88 · see citing works

Oxidative Modification of Alpha-Synuclein Modifies its Cytotoxicity

Falomir‐Lockhart, L. J., Borsarelli, C. D., Ostatná, V., Fauerbach, J. A., Paleček, E., Jares-Erijman, E. A., & Jovin, T. M. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2011.11.1402

Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease

Poon, H. F., Frasier, M. A., Shreve, N., Calabrese, V., Wolozin, B. L., & Butterfield, D. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.009 · Cited by 165 · see citing works

Symposium 3: Function and Pathogenesis in Parkinson’s Disease. Synuclein: the third amyloid in Alzheimer's disease

Trojanowski, J. Q. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.81.s1.49_1.x